Preliminary experiments suggest conolidine could inhibit particular ion channels, reducing neuronal excitability and restricting discomfort alerts. This system is particularly related in neuropathic suffering, where by irregular signaling brings about persistent pain. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathwa